Drugs / DA-5207
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05127746 | Nov 2021 → Dec 2022 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT04479865 | Jul → Dec 2020 | — | Dong-A ST Co., Ltd. | Unknown | No outcome recorded |
| Phase 1 | NCT04013477 | Jun → Dec 2019 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-5207 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04479865 ↗ |
| Route | Other | “DA-5207 Transdermal Delivery System” NCT04013477 ↗ |